ImmunoGen Reports Recent Progress and 2018 Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. BA
5. STX
6. V
7. CSGP
8. LSTR
9. UPS
10. KIDS

Go back to ImmunoGen Reports Recent Progress and 2018 Operating Results

Immunogen (IMGN) Tops Q4 EPS by 4c, FY Revenue Guidance Misses

February 8, 2019 6:36 AM EST

Immunogen (NASDAQ: IMGN) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $12.27 million.

GUIDANCE:

Immunogen sees FY2019 revenue of $40-45 million, versus the consensus of $84.56... More